Medicalsystem Biotechnology (300439.SZ) obtained a medical device registration certificate.

17:32 03/04/2026

Meikang Biology (300439.SZ) announces that the company has recently obtained a medical device registration certificate issued by the National Medical Products Administration. The product is named: Glucose-6-phosphate dehydrogenase assay kit (glucose-6-phosphate substrate method).

Medicalsystem Biotechnology (300439.SZ) announced that the company recently obtained a medical device registration certificate issued by the National Medical Products Administration. The product is named: Glucose-6-phosphate dehydrogenase assay kit (glucose-6-phosphate substrate method).

New stock news | Shenzhen Salubris Pharmaceuticals (002294.SZ) plans to list on the Hong Kong Stock Exchange. The China Securities Regulatory Commission requires clarification on the proportion of fundraising for domestic and overseas purposes.

The Shanghai Stock Exchange releases the annual report of publicly offered Real Estate Investment Trusts (REITs) in the Shanghai market for 2025: A total of 52 products generated a combined revenue of 14.5 billion yuan for the year, representing a 71% year-on-year increase.

Zhixiang Jintai (688443.SH) plans to launch a restricted stock incentive plan in 2026.